Lead Plaintiffs Seek Class Certification In Securities Suit Against Drug Maker
BOSTON — A federal judge should grant a motion for class certification filed by lead plaintiffs in a securities class action lawsuit against a biopharmaceutical company and certain of its executive...To view the full article, register now.
Already a subscriber? Click here to view full article